- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$14.0b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$227.41
7D
-0.04%
1Y
37.0%
Madrigal Pharmaceuticals
Market Cap: US$10.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$442.00
7D
2.4%
1Y
29.7%
Insmed
Market Cap: US$31.0b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$142.70
7D
2.4%
1Y
80.8%
Alnylam Pharmaceuticals
Market Cap: US$42.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$314.80
7D
-1.8%
1Y
24.2%
BridgeBio Pharma
Market Cap: US$13.8b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$70.12
7D
-1.8%
1Y
107.8%
BeOne Medicines
Market Cap: US$31.9b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$282.29
7D
-5.6%
1Y
6.0%
Ionis Pharmaceuticals
Market Cap: US$11.9b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$71.67
7D
-4.2%
1Y
115.0%
AbbVie
Market Cap: US$388.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$208.34
7D
-8.5%
1Y
-1.8%
Jazz Pharmaceuticals
Market Cap: US$11.2b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$180.45
7D
-2.7%
1Y
27.0%
Eli Lilly
Market Cap: US$831.1b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$918.05
7D
-8.2%
1Y
9.7%
BioMarin Pharmaceutical
Market Cap: US$10.8b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.43
7D
-8.1%
1Y
-22.3%
Natera
Market Cap: US$28.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$197.79
7D
0.6%
1Y
31.1%
Royalty Pharma
Market Cap: US$26.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.79
7D
-1.9%
1Y
37.1%
Viatris
Market Cap: US$15.9b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.74
7D
-1.6%
1Y
45.9%
Exact Sciences
Market Cap: US$19.8b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.75
7D
0.3%
1Y
127.0%
Elanco Animal Health
Market Cap: US$12.5b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.83
7D
5.9%
1Y
129.3%
Waters
Market Cap: US$29.1b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$295.05
7D
-0.8%
1Y
-20.5%